A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart-Reference-Cited by-同舟云学术

A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart

Published:2018-08 Issue:1-2 Volume:547 Page:368-376
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Tran The-Thien,Vidaillac Celine,Yu Hong,Yong Valerie F.L.,Roizman Dan,Chandrasekaran Ravishankar,Lim Albert Y.H.,Low Teck Boon,Tan Gan Liang,Abisheganaden John A.,Koh Mariko Siyue,Teo Jeanette,Chotirmall Sanjay H.,Hadinoto Kunn

Funder

LKCMedicine

Nanyang Technological University

Singapore Ministry of Health’s National Medical Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis;Aksamit;Eur. Respir. J.,2018

2. A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus;Barber;Antimicrob. Agents Ch.,2014

3. Chapter 1: Bronchiectasis: epidemiology and causes;Bilton;Eur. Respir. Mon.,2011

4. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial;Bilton;Thorax,2014

5. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa;Brazas;Antimicrob. Agents Ch.,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dry Powder Inhaler Formulation of Lactobacillus rhamnosus GG Targeting Pseudomonas aeruginosa Infection in Bronchiectasis Maintenance Therapy;Pharmaceutics;2024-07-25

2. Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives;Pharmaceutics;2024-05-11

3. Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery;Journal of Pharmaceutical Investigation;2024-02-08

4. The Respiratory Microbiome in Paediatric Chronic Wet Cough: What Is Known and Future Directions;Journal of Clinical Medicine;2023-12-28

5. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport;Chemical Society Reviews;2023